DOR-EGFP reporter mice have the opioid receptor, delta 1 (Oprd1) gene driving expression of an enhanced green fluorescent protein. These mice may be useful as a means for visualizing receptor neuroanatomy and real-time receptor trafficking in live neurons.
Brigitte L. Kieffer, McGill University
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Reporter, Null/Knockout) | Oprd1 | opioid receptor, delta 1 |
DOR-EGFP reporter mice have an enhanced green fluorescent protein (EGFP) knocked into the last exon of the opioid receptor, delta 1 (Oprd1) gene. DOR-EGFP mice have EGFP inserted just upstream of the stop codon of the targeted gene, allowing this strain to express endogenous Oprd1-encoded receptors with a fused EGFP at the C-terminus. Mice homozygous for this allele are viable and fertile. δ-opioid receptors (DORs) are G-protein-coupled receptors that inhibit neuronal activity upon binding of ligands such as enkephalins and other opioids. DORs are targets for the treatment of chronic pain, drug abuse, and emotional disorders.
Mice emit EGFP fluorescence in neurons in the caudate putamen at birth, in the hippocampus at day 3 after birth, with increasing expression throughout the brain reaching maximal intensity at day 15. Although, Oprd1 transcription, receptor numbers, and activation is slightly increased in DOR-EGFP mice compared to wild-type animals, affinity of the receptor for agonists and endogenous peptides is unchanged. Treatment with receptor agonists triggers receptor internalization, with cell surface fluorescence decreasing in a dose-dependent manner. This correlates with a rapid and dose-dependent increase of locomotor activity. Mice with internalized receptors are insensitive to subsequent agonist administration.
When crossed to MOR-mCherry mice (Stock No. 029013), expressing mCherry in mu opioid receptors, bicolor double mutant mice (DOR-eGFP/MORmcherry) express functional fluorescent forms of the two receptors.
A targeting vector was designed by Dr. Brigitte Kieffer's reasearch team to insert an enhanced green fluorescent protein (EGFP), and a loxP-flanked hygromycin resistance (hygro) cassette, in exon 3, just upstream of the stop codon, of the opioid receptor, delta 1 (Oprd1) coding region. The construct was electroporated into 129svPas-derived embryonic stem (ES) cells. Correctly targeted ES cells were transiently transfected with a cre recombinase expression plasmid to delete the hygro cassette and resulting chimeric mice were crossed C57BL/6J mice (Stock No. 000664). Upon arrival at The Jackson Laboratory, cryopreserved sperm was used to fertilize C57BL/6J oocytes (Stock No. 000664) to establish our live colony of DOR-EGFP reporter mice.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Site of Expression | EGFP fluorescence is expressed in neurons of the brain. |
Allele Name | targeted mutation 2, Brigitte L Kieffer |
---|---|
Allele Type | Targeted (Reporter, Null/Knockout) |
Allele Synonym(s) | DOReGFP; DORGFP |
Gene Symbol and Name | Oprd1, opioid receptor, delta 1 |
Gene Synonym(s) | |
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | EGFP fluorescence is expressed in neurons of the brain. |
Strain of Origin | 129S2/SvPas |
Chromosome | 4 |
Molecular Note | Homologous recombination was used to introduce the EGFP cDNA into exon 3 in frame and upstream of the stop codon. Western blot demonstrated expression of an EGFP protein as expected. Quantitative mRNA analysis demonstrated that the insertion did not interrupt normal transcription of the locus. |
When maintaining a live colony, homozygotes may be bred together.
When using the DOR-EGFP mouse strain in a publication, please cite the originating article(s) and include JAX stock #029012 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Oprd1<tm2Kff> |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.